Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
- Gold slips after Bernanke hints at slowing bond buys
- FBI says man shot dead while being questioned about Boston bombings
- British soldier hacked to death in suspected Islamist attack
- Soldier hacked to death in London in suspected Islamist attack
- Short story writer Lydia Davis wins Man Booker International fiction prize
REUTERS SHOWCASE
Tax Avoidance
EU leaders talk tough on tackling Amazon, Google over taxes. Full Article | Related Story
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Rupee drops for third day in a row; oil demand hurts
1 of 2. A shopkeeper poses for a picture as he counts currency notes at his shop in Jammu May 16, 2012.
Credit: Reuters/Mukesh Gupta/Files
MUMBAI |
MUMBAI (Reuters) - The rupee weakened for a third straight session on Thursday as persistent dollar buying by oil refiners and absence of major dollar inflows due to a holiday in the United States hurt the local unit.
Traders are also growing wary of India's fiscal stance after a government source said fiscal deficit could reach 5.5 to 5.6 percent of its GDP in the financial year to end March, which could require additional market borrowing of 350-400 billion rupees.
"Personally, I continue to run moderately short USD positions even at this stage. I do not agree to the consensus of 56-57 levels on the pair and think the rupee can appreciate hereon with a second round of capital inflows," said Samir Lodha, managing director at QuantArt Market Solutions.
The partially convertible rupee closed at 55.21/22 per dollar versus its previous close of 55.11/12.
Traders estimated about $200 million worth of dollar demand, which they attributed to Cipla (CIPL.NS), after the drug maker said on Wednesday it would offer $215 million for a majority stake in South Africa's Cipla Medpro (CMPJ.J).
The absence of major flows due to the Thanksgiving holiday in the United States also weighted on the rupee.
Dealers expect the pair to move in a 54.50 to 55.50 range in the immediate future, pending developments at the winter session of parliament which started on Thursday.
"The winter session will be key. The rally seen in the rupee post the reforms announcement was short-lived, but even a small negative is hurting the rupee," a senior dealer with a state-run bank said. The dealer predicted the rupee to remain in a 54.80 to 56 range, and head above 56 by year-end.
In the offshore non-deliverable forwards market, one-month contract was at 55.51, while the three-month was at 56.09.
In the currency futures market, the most-traded near-month dollar/rupee contracts on the National Stock Exchange, the MCX-SX and the United Stock Exchange all closed at around 55.25 with a total traded volume of $4.3 billion. (Editing by Prateek Chatterjee)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints








Follow Reuters